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A patient with Turners syndrome and type II respiratory failure is described. Treatment
with non-invasive ventilation alone was unsuccessful, but was sufficient to manage the
patient once tracheomalacia had been identified and treated with a tracheal stent.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Tracheomalacia is a rare and potentially fatal condition. In
the current literature, it is increasingly recognised in both
adults and children. It has not previously been described in a
patient with Turner’s syndrome and is not commonly thought
of as a cause of failure to ventilate with non-invasive
ventilation (NIV). We present a case of a 52-year-old women
with Turner’s syndrome who was found to have tracheoma-
lacia when she became increasingly difficult to ventilate;
successfully treated with an intra-tracheal stent.
Description of case
The 52-year-old woman was transferred to our unit following
an acute admission to another hospital with type II
respiratory failure, which became compounded by a hospitalElsevier Ltd. All rights reserved.
ctors.org.uk (S. Bloch).acquired pneumonia. Prior to admission she described
increasing hypersomnolence, loud snoring and morning
headache consistent with sleep disordered breathing.
She had the typical phenotype of Turner’s syndrome, short
stature, a short, webbed neck and obesity. Her nasopharynx
was crowded and she was noted to have a high-pitched voice,
but other than occasional crepitations at her lung bases and
marked peripheral oedema, her examination was normal.
Arterial blood gasses on admission showed a H+ 44.9, PaCO2
12.9 kPa, PaO2 11.0kPa breathing 1 l O2 via nasal cannulae.
A chest X-ray showed an elevated right hemi-diaphragm
and alveolar shadowing at the bases. A provisional diagnosis
of obstructive sleep apnoea (OSA)/obesity hypoventilation
overlap syndrome was made. Echocardiography showed
good left ventricular function, but mild impairment and
dilatation of the right ventricle. She was offered NIV
aggressively, trying a range of machines and interventions
but continued to deteriorate. Overnight respiratory mon-
itoring revealed severe desaturation to less than 60% and a
gradual rise in transctaneous CO2 over night to 18 kPa. Blood
gases that morning revealed acute on chronic acidotic
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Figure 1 The trachea at rigid bronchoscopy in jet ventilation (left) and passive expiration (right).
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8.5 kPa, HCO3 52. She was drowsy and increasingly difficult
to ventilate, with little air movement in the chest despite
applied airway pressures greater than 30 cm H2O. For this
reason and because of concern about an upper airway
lesion, it was considered that intubation and investigation of
her upper airways was warranted.
She was intubated and ventilated and subsequently a
tracheostomy, guided by ridgid bronchoscopy, was per-
formed by the thoracic surgeons. At the time during passive
expiration prolapse of the posterior tracheal wall was
sufficient to almost completely occlude the airway. Fiber-
optic bronchoscopy via tracheostomy tube revealed that the
tracheomalacia also involved the main bronchi (Figure 1).
Pressures of more than 35 were required to keep the airway
patent, despite thorough treatment of her pneumonia.
Following discussion with the patient, a 20 60mm un-
covered metal stent was inserted in to the trachea.
Following this she did well, quickly mobilising and eating
and drinking normally, and only requiring overnight NIV
(Breas 403). Repeat overnight respiratory monitoring
showed stable transcutaneous CO2 and only minor oxygen
desaturation.Discussion
Turner’s syndrome is the genetic syndrome occurring from
the karyotype 45 X0. It occurs in about 1 in 2000 live female
births but a larger proportion of spontaneously aborting
foetuses. It is associated with thyroid problems, cardiac and
renal anomalies, infertility and hearing impairment. The
phenotype is of characteristic short stature, short 4th
metacarpals, widened carrying angle, a shield chest and a
webbed shortened neck. Turner’s patients are often obese1;
along with the above associations obesity is thought to
contribute to the shortened life expectancy of these
patients.
Obesity hypoventilation is a recognised cause of chronic
type II respiratory failure and along with OSA results in
pulmonary hypertension and irreversible lung damage.
Tracheomalacia is most commonly associated with trachealintubation and tracheostomy; however, outside these con-
ditions it can be primary or secondary. Primary causes
mainly related to congenital malformation or cartilaginous
disorders. Secondary causes include recurrent inflammation
of the airways or external pressure.2
This case raises two important questions. The first is
whether tracheomalacia may be more common in obesity
than previously considered; such patients seldom come to
bronchoscopy and the usual treatment for obesity hypoven-
tilation, non-invasive positive pressure ventilation, is
also a recognised treatment for tracheomalacia.3 Tracheo-
malacia would also be consistent with the flow volume loops
showing extra-thoracic compression seen in some obese
patients.
Secondly, the possibility arises that tracheomalacia could
be a part of the Turner’s phenotype. Patients with Turner’s
syndrome are as discussed at increased risk of obesity and
therefore have increased risk of OSA and obesity hypoventi-
lation. But recent research is increasingly implicating the X-
chromosome in linear growth and development of both bone
and cartilage. It has been demonstrated that the short
stature and phenotype of the Turner’s patient is caused by
the lack of the SHOX (short stature homebox) gene. This
gene is not only implicated in idiopathic short stature, but
also Leri–Weill Dyschondrosteosis and other genetic syn-
dromes including bony abnormalities of the wrist, abnormal
short stature, hearing problems and craniofacial abnormal-
ities.4,5 These connections lead to the hypothesis that the
underlying genetic abnormality in our and other Turner’s
syndrome patients renders their tracheal cartilage more at
risk from tracheomalacia.
This case serves to increase our awareness of tracheoma-
lacia and suggest increased investigation to diagnose and
treat the condition in obese patients with hypoventilation
syndromes. Tracheal stenting is an option where other
treatment modalities have been ineffective.Conflict of interest statement
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